Coya Therapeutics, Inc. Common Stock (COYA) is a publicly traded Healthcare sector company. As of May 21, 2026, COYA trades at $4.64 with a market cap of $115.41M and a P/E ratio of -4.62. COYA moved +0.77% today. Year to date, COYA is -13.81%; over the trailing twelve months it is -21.16%. Its 52-week range spans $3.71 to $10.24. Analyst consensus is strong buy with an average price target of $16.25. Rallies surfaces COYA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own COYA include DME Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Coya Therapeutics, Inc. Common Stock.
| Metric | Value |
|---|---|
| Price | $4.64 |
| Market Cap | $115.41M |
| P/E Ratio | -4.62 |
| EPS | $-0.98 |
| Dividend Yield | 0.00% |
| 52-Week High | $10.24 |
| 52-Week Low | $3.71 |
| Volume | 10 |
| Avg Volume | 0 |
| Revenue (TTM) | $3.55M |
| Net Income | $-14.88M |
| Gross Margin | 0.00% |
4 analysts cover COYA: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $16.25.